Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 13.71 1.48% 0.20
ALDR closed up 1.48 percent on Monday, March 18, 2019, on 51 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ALDR trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bullish Centerline Cross Bullish 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 15 MACD Bullish Signal Line Cross Bullish 1.48%
Mar 15 Spinning Top Other 1.48%
Mar 14 Crossed Above 20 DMA Bullish 0.96%
Mar 14 180 Bullish Setup Bullish Swing Setup 0.96%
Mar 13 20 DMA Resistance Bearish 5.79%
Mar 12 50 DMA Support Bullish 4.82%
Mar 12 Oversold Stochastic Weakness 4.82%
Mar 11 Crossed Above 50 DMA Bullish 7.36%

Older signals for ALDR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Medicine Health Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Rheumatoid Arthritis Bristol Myers Squibb Migraine Prevention Of Migraine Psoriatic Arthritis
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.869
52 Week Low 9.44
Average Volume 1,003,831
200-Day Moving Average 14.9504
50-Day Moving Average 12.9414
20-Day Moving Average 13.254
10-Day Moving Average 12.921
Average True Range 0.6669
ADX 20.71
+DI 25.1323
-DI 23.0609
Chandelier Exit (Long, 3 ATRs ) 12.9493
Chandelier Exit (Short, 3 ATRs ) 13.8207
Upper Bollinger Band 14.7071
Lower Bollinger Band 11.8009
Percent B (%b) 0.66
BandWidth 21.926965
MACD Line 0.0215
MACD Signal Line -0.0297
MACD Histogram 0.0512
Fundamentals Value
Market Cap 928.35 Million
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -2.67
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.25
Resistance 3 (R3) 14.24 14.04 14.16
Resistance 2 (R2) 14.04 13.91 14.05 14.13
Resistance 1 (R1) 13.88 13.82 13.96 13.89 14.10
Pivot Point 13.68 13.68 13.73 13.69 13.68
Support 1 (S1) 13.52 13.55 13.60 13.53 13.32
Support 2 (S2) 13.32 13.46 13.33 13.29
Support 3 (S3) 13.16 13.32 13.26
Support 4 (S4) 13.17